Do analysts rate INGN or BDMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, INGN or BDMD?

Baird Medical Investment has lower revenue, but higher earnings than Inogen. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inogen $348.67M 0.47 -$22.75M -$0.90 N/A Baird Medical Investment $22.54M 2.22 N/A N/A N/A

Does the media favor INGN or BDMD?

In the previous week, Inogen had 8 more articles in the media than Baird Medical Investment. MarketBeat recorded 9 mentions for Inogen and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Inogen's score of 0.28 indicating that Baird Medical Investment is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate BDMD or APYX?

Apyx Medical has a consensus price target of $6.60, suggesting a potential upside of 90.75%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts plainly believe Apyx Medical is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Apyx Medical 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.71

Which has better earnings & valuation, BDMD or APYX?

Baird Medical Investment has higher earnings, but lower revenue than Apyx Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 2.22 N/A N/A N/A Apyx Medical $52.84M 2.76 -$11.21M -$0.20 N/A

Does the media refer more to BDMD or APYX?

In the previous week, Apyx Medical had 20 more articles in the media than Baird Medical Investment. MarketBeat recorded 21 mentions for Apyx Medical and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Apyx Medical's score of 0.58 indicating that Baird Medical Investment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apyx Medical 3 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Do analysts rate STIM or BDMD?

Neuronetics currently has a consensus target price of $4.00, indicating a potential upside of 84.33%. Given Neuronetics' stronger consensus rating and higher probable upside, research analysts clearly believe Neuronetics is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neuronetics 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, STIM or BDMD?

Baird Medical Investment has lower revenue, but higher earnings than Neuronetics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neuronetics $149.16M 1.01 -$39M -$0.54 N/A Baird Medical Investment $22.54M 2.22 N/A N/A N/A

Does the media prefer STIM or BDMD?

In the previous week, Neuronetics had 4 more articles in the media than Baird Medical Investment. MarketBeat recorded 5 mentions for Neuronetics and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Neuronetics' score of 0.05 indicating that Baird Medical Investment is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neuronetics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend BDMD or OWLT?

Owlet has a consensus target price of $15.00, suggesting a potential upside of 175.74%. Given Owlet's stronger consensus rating and higher probable upside, analysts plainly believe Owlet is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Owlet 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has better valuation and earnings, BDMD or OWLT?

Baird Medical Investment has higher earnings, but lower revenue than Owlet. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 2.22 N/A N/A N/A Owlet $105.70M 1.50 -$39.68M -$3.07 N/A

Is BDMD or OWLT more profitable?

Baird Medical Investment has a net margin of 0.00% compared to Owlet's net margin of -42.54%. Company Net Margins Return on Equity Return on Assets Baird Medical Investment N/A N/A N/A Owlet -42.54% N/A -18.02%

Does the media favor BDMD or OWLT?

In the previous week, Baird Medical Investment and Baird Medical Investment both had 1 articles in the media. Baird Medical Investment's average media sentiment score of 0.99 beat Owlet's score of 0.00 indicating that Baird Medical Investment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Owlet 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate CVRX or BDMD?

CVRx currently has a consensus target price of $6.90, suggesting a potential upside of 191.14%. Given CVRx's stronger consensus rating and higher possible upside, equities analysts plainly believe CVRx is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.33 Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, CVRX or BDMD?

Baird Medical Investment has lower revenue, but higher earnings than CVRx. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 1.11 -$53.31M -$1.98 N/A Baird Medical Investment $22.54M 2.22 N/A N/A N/A

Does the media prefer CVRX or BDMD?

In the previous week, CVRx had 21 more articles in the media than Baird Medical Investment. MarketBeat recorded 22 mentions for CVRx and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat CVRx's score of -0.46 indicating that Baird Medical Investment is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 4 Negative mention(s) 2 Very Negative mention(s) Neutral Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Baird Medical Investment (BDMD) Competitors

$1.22 0.00 (0.00%)

Closing price 08/10/2026 04:00 PM Eastern

Extended Trading

$1.25 +0.03 (+2.05%)

As of 05:29 AM Eastern

Compare

BDMD vs. INGN, APYX, STIM, OWLT, and CVRX

Should you buy Baird Medical Investment stock or one of its competitors? Baird Medical Investment's main competitors and comparable companies include Inogen (INGN), Apyx Medical (APYX), Neuronetics (STIM), Owlet (OWLT), and CVRx (CVRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Baird Medical Investment compare to Inogen?

Inogen (NASDAQ:INGN) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

89.9% of Inogen shares are held by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are held by institutional investors. 2.5% of Inogen shares are held by company insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Inogen has a beta of 1.55, suggesting that its share price is 55% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.16, suggesting that its share price is 216% less volatile than the broader market.

Baird Medical Investment has a net margin of 0.00% compared to Inogen's net margin of -6.94%. Baird Medical Investment's return on equity of 0.00% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-6.94%	-13.17%	-8.36%
Baird Medical Investment	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Inogen had 8 more articles in the media than Baird Medical Investment. MarketBeat recorded 9 mentions for Inogen and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Inogen's score of 0.28 indicating that Baird Medical Investment is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inogen	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Baird Medical Investment has lower revenue, but higher earnings than Inogen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$348.67M	0.47	-$22.75M	-$0.90	N/A
Baird Medical Investment	$22.54M	2.22	N/A	N/A	N/A

Summary

Inogen and Baird Medical Investment tied by winning 6 of the 12 factors compared between the two stocks.

How does Baird Medical Investment compare to Apyx Medical?

Baird Medical Investment (NASDAQ:BDMD) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by company insiders. Comparatively, 15.9% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Baird Medical Investment has higher earnings, but lower revenue than Apyx Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	2.22	N/A	N/A	N/A
Apyx Medical	$52.84M	2.76	-$11.21M	-$0.20	N/A

Apyx Medical has a consensus price target of $6.60, suggesting a potential upside of 90.75%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts plainly believe Apyx Medical is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

In the previous week, Apyx Medical had 20 more articles in the media than Baird Medical Investment. MarketBeat recorded 21 mentions for Apyx Medical and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Apyx Medical's score of 0.58 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	3 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Baird Medical Investment has a beta of -1.16, indicating that its share price is 216% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market.

Baird Medical Investment has a net margin of 0.00% compared to Apyx Medical's net margin of -14.78%. Baird Medical Investment's return on equity of 0.00% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Apyx Medical	-14.78%	-76.60%	-13.91%

Summary

Apyx Medical beats Baird Medical Investment on 9 of the 14 factors compared between the two stocks.

How does Baird Medical Investment compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are owned by institutional investors. 8.4% of Neuronetics shares are owned by insiders. Comparatively, 78.9% of Baird Medical Investment shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Baird Medical Investment has lower revenue, but higher earnings than Neuronetics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$149.16M	1.01	-$39M	-$0.54	N/A
Baird Medical Investment	$22.54M	2.22	N/A	N/A	N/A

In the previous week, Neuronetics had 4 more articles in the media than Baird Medical Investment. MarketBeat recorded 5 mentions for Neuronetics and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Neuronetics' score of 0.05 indicating that Baird Medical Investment is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neuronetics	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Neuronetics has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.16, suggesting that its stock price is 216% less volatile than the broader market.

Baird Medical Investment has a net margin of 0.00% compared to Neuronetics' net margin of -24.48%. Baird Medical Investment's return on equity of 0.00% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-24.48%	-139.83%	-27.13%
Baird Medical Investment	N/A	N/A	N/A

Neuronetics currently has a consensus target price of $4.00, indicating a potential upside of 84.33%. Given Neuronetics' stronger consensus rating and higher probable upside, research analysts clearly believe Neuronetics is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Neuronetics beats Baird Medical Investment on 7 of the 13 factors compared between the two stocks.

How does Baird Medical Investment compare to Owlet?

Baird Medical Investment (NASDAQ:BDMD) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Baird Medical Investment has a beta of -1.16, indicating that its share price is 216% less volatile than the broader market. Comparatively, Owlet has a beta of 1.85, indicating that its share price is 85% more volatile than the broader market.

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by company insiders. Comparatively, 36.2% of Owlet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Baird Medical Investment has a net margin of 0.00% compared to Owlet's net margin of -42.54%.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Owlet	-42.54%	N/A	-18.02%

In the previous week, Baird Medical Investment and Baird Medical Investment both had 1 articles in the media. Baird Medical Investment's average media sentiment score of 0.99 beat Owlet's score of 0.00 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Owlet	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Owlet has a consensus target price of $15.00, suggesting a potential upside of 175.74%. Given Owlet's stronger consensus rating and higher probable upside, analysts plainly believe Owlet is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Baird Medical Investment has higher earnings, but lower revenue than Owlet.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	2.22	N/A	N/A	N/A
Owlet	$105.70M	1.50	-$39.68M	-$3.07	N/A

Summary

Owlet beats Baird Medical Investment on 6 of the 11 factors compared between the two stocks.

How does Baird Medical Investment compare to CVRx?

CVRx (NASDAQ:CVRX) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

CVRx has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.16, indicating that its stock price is 216% less volatile than the broader market.

Baird Medical Investment has lower revenue, but higher earnings than CVRx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	1.11	-$53.31M	-$1.98	N/A
Baird Medical Investment	$22.54M	2.22	N/A	N/A	N/A

CVRx currently has a consensus target price of $6.90, suggesting a potential upside of 191.14%. Given CVRx's stronger consensus rating and higher possible upside, equities analysts plainly believe CVRx is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.33
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

75.3% of CVRx shares are held by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are held by institutional investors. 16.6% of CVRx shares are held by company insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Baird Medical Investment has a net margin of 0.00% compared to CVRx's net margin of -84.93%. Baird Medical Investment's return on equity of 0.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Baird Medical Investment	N/A	N/A	N/A

In the previous week, CVRx had 21 more articles in the media than Baird Medical Investment. MarketBeat recorded 22 mentions for CVRx and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat CVRx's score of -0.46 indicating that Baird Medical Investment is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	1 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	4 Negative mention(s)	2 Very Negative mention(s)	Neutral
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

CVRx beats Baird Medical Investment on 8 of the 14 factors compared between the two stocks.

Get Baird Medical Investment News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BDMD vs. The Competition

Export

Metric	Baird Medical Investment	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$49.99M	$5.84B	$7.02B	$12.98B
Dividend Yield	N/A	1.78%	2.58%	10.06%
P/E Ratio	N/A	24.72	269.18	24.72
Price / Sales	2.22	39.71	585.29	95.49
Price / Cash	N/A	33.55	28.89	37.42
Price / Book	N/A	6.21	11.26	6.42
Net Income	N/A	$147.87M	$3.45B	$347.03M
7 Day Performance	10.91%	1.08%	1.91%	0.71%
1 Month Performance	7.96%	1.65%	-0.58%	-0.87%
1 Year Performance	-43.52%	5.39%	75.47%	21.94%

Baird Medical Investment Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BDMD Baird Medical Investment	1.4063 of 5 stars	$1.22 flat	N/A	-45.3%	$49.99M	$22.54M	N/A	N/A	News Coverage
INGN Inogen	1.2645 of 5 stars	$6.52 -5.9%	N/A	-7.1%	$176.56M	$348.67M	N/A	1,030	Earnings Report
APYX Apyx Medical	3.0617 of 5 stars	$4.14 -3.2%	$6.60 +59.4%	+58.7%	$173.55M	$52.84M	N/A	270	Trending News Earnings Report Analyst Revision Gap Down
STIM Neuronetics	3.2304 of 5 stars	$2.42 +5.0%	$4.00 +65.6%	-47.5%	$165.28M	$149.16M	N/A	180
OWLT Owlet	2.3058 of 5 stars	$5.60 +4.9%	$15.00 +167.7%	-41.8%	$162.74M	$105.70M	N/A	106	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BDMD) was last updated on 8/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baird Medical Investment (BDMD) Competitors

BDMD vs. INGN, APYX, STIM, OWLT, and CVRX

How does Baird Medical Investment compare to Inogen?

Summary

How does Baird Medical Investment compare to Apyx Medical?

Summary

How does Baird Medical Investment compare to Neuronetics?

Summary

How does Baird Medical Investment compare to Owlet?

Summary

How does Baird Medical Investment compare to CVRx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD vs. The Competition

Baird Medical Investment Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Baird Medical Investment (BDMD) Competitors

BDMD vs. INGN, APYX, STIM, OWLT, and CVRX

How does Baird Medical Investment compare to Inogen?

Do institutionals and insiders believe in INGN or BDMD?

Which has more volatility and risk, INGN or BDMD?

Is INGN or BDMD more profitable?

Do analysts rate INGN or BDMD?

Does the media favor INGN or BDMD?

Which has higher valuation and earnings, INGN or BDMD?

Summary

How does Baird Medical Investment compare to Apyx Medical?

Do insiders & institutionals believe in BDMD or APYX?

Which has better earnings & valuation, BDMD or APYX?

Do analysts rate BDMD or APYX?

Does the media refer more to BDMD or APYX?

Which has more volatility and risk, BDMD or APYX?

Is BDMD or APYX more profitable?

Summary

How does Baird Medical Investment compare to Neuronetics?

Do insiders and institutionals have more ownership in STIM or BDMD?

Which has preferable valuation and earnings, STIM or BDMD?

Does the media prefer STIM or BDMD?

Which has more risk and volatility, STIM or BDMD?

Is STIM or BDMD more profitable?

Do analysts rate STIM or BDMD?

Summary

How does Baird Medical Investment compare to Owlet?

Which has more volatility & risk, BDMD or OWLT?

Do institutionals and insiders hold more shares of BDMD or OWLT?

Is BDMD or OWLT more profitable?

Does the media favor BDMD or OWLT?

Do analysts recommend BDMD or OWLT?

Which has better valuation and earnings, BDMD or OWLT?

Summary

How does Baird Medical Investment compare to CVRx?

Which has more volatility and risk, CVRX or BDMD?

Which has better valuation and earnings, CVRX or BDMD?

Do analysts rate CVRX or BDMD?

Do institutionals & insiders have more ownership in CVRX or BDMD?

Is CVRX or BDMD more profitable?

Does the media prefer CVRX or BDMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD vs. The Competition

Baird Medical Investment Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools